REGN
REGENERON PHARMACEUTICALS, INC.
Key Financials
Net Income
$4.5B
↑ 2.1%
Revenue
$14.3B
↑ 1.0%
Operating Income
$3.6B
↓ 10.3%
Total Assets
$40.6B
↑ 7.4%
EPS (Diluted)
$41.48
↑ 8.2%
Shareholders' Equity
$31.3B
↑ 6.5%
Cash & Equivalents
$3.1B
↑ 25.3%
Total Liabilities
$9.3B
↑ 10.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | REGN |
| Company Name | REGENERON PHARMACEUTICALS, INC. |
| CIK | 872589 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NY |
| Phone | 9148477000 |